Jiangsu Biomedical Industry Output To Exceed RMB 500 Billion By 2012
This article was originally published in PharmAsia News
The Jiangsu provincial government agreed to formal introduction of the Science and Technology Department's proposed "Jiangsu Province Biotechnology and Pharmaceutical Industry Development Plan" (2009-2012), which sets a target total industry output value of RMB 500 billion by 2012
You may also be interested in...
Biocon Biologics upbeat on Lantus follow-on’s long revenue stream and prospects for interchangeability, while operational challenges resulted in some supply constraints during the fiscal second quarter.
During a recent press briefing, health officials in China disclosed the country is poised to reach an annual production capacity of 610 million doses for coronavirus vaccines. But they said prices must be based on manufacturing costs and not driven by supply and demand.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.